Related Experiment Video

Updated: Mar 31, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Role of Ezetimibe in Lipid-Lowering and Cardiovascular Disease Prevention

Bryan A Smith1, Charmaine Wright2, Michael Davidson3

  • 1Department of Cardiology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA. Bryan.Smith2@uchospitals.edu.

Current Atherosclerosis Reports
|October 23, 2015
PubMed

Insights

Adding ezetimibe to statin therapy significantly lowers low-density lipoprotein cholesterol (LDL-C) and reduces cardiovascular mortality. This combination offers a safe and effective strategy for patients not achieving LDL-C goals with statins alone.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Statins are primary therapy for reducing cardiovascular events by lowering LDL-C.
  • Emerging evidence suggests further LDL-C reduction may enhance cardiovascular risk mitigation.
  • Guidelines now support more aggressive LDL-C lowering targets.

Purpose of the Study:

  • To evaluate the efficacy and safety of ezetimibe as an adjunct to statin therapy for LDL-C reduction.
  • To assess the impact of combined therapy on cardiovascular outcomes and mortality.

Main Methods:

  • Investigated ezetimibe, a cholesterol absorption inhibitor targeting the NPC1L1 receptor.
  • Focused on patient populations not at LDL-C goal with statin monotherapy.
  • Analyzed data from recent clinical trials on combination therapy.

Main Results:

  • Ezetimibe, when added to statins, further reduces LDL-C levels effectively.
  • The combination therapy is well-tolerated with no significant adverse effects.
  • Significant mortality benefits were observed in patients receiving combination therapy.

Conclusions:

  • Ezetimibe is a safe and effective add-on therapy to statins for lowering LDL-C.
  • This combination strategy provides substantial cardiovascular risk reduction and mortality benefit.
  • Achieving lower LDL-C targets with combination therapy is beneficial for high-risk patients.

Keywords:
CholesterolEzetimibeLDLLDL hypothesisVytorin

More Related Videos

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.9K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.3K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
959
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
851
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.9K
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.6K